Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Remifentanil-Nicardipine for Controlled Hypotension in Otolaryngological Surgery
NCT07659496Not yet recruiting
- Sponsor
- Dicle University
- Start
- Jun 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Trial of nicardipine in hypotension (2 arms), sponsored by Dicle University. Primary endpoints: Cardiac Index up to 3 hours, Stroke Volume Index up to 3 hours and 2 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
nicardipine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT07659496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07659496.